http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0502997-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7d241434dd2e686fcc5aab7061164f8c
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-217
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
filingDate 1990-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4f1b369c50977389a818d6b9cb75c058
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5343027c5e7df90c8801cb15cd8b9cfd
publicationDate 1992-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0502997-A1
titleOfInvention TREATING ATOPIC DISEASES WITH GAMMA INTERFERON.
abstract A method of treating patients with severe chronic allergic disorders, such as constitutional eczema or steroid-related asthma, using gamma interferon. The method involves treating patients with constitutional eczema or steroid-related asthma using effective dosages of gamma interferons, which reduces the clinical severity of their disease.
priorityDate 1989-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100188894
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396436
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID396054
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID449565
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396435
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID109644000
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4112
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284373
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19649
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID449517
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCE1BNK3
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID287287
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3458
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2153
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID403785
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID25712
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID16189
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID405790
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID396991
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCF1PKH2
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394438
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID574282
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID126941
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID281237
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCF1PI70
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID397225
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395835
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ66I23
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3565
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCF1R741
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24749
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID280824
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57199466
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID403801
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395836
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCF6ZYQ1
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCH0YX95
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCA6QP91
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57417230
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCA0A286ZV08
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID15978
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395500
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396811
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCF6U272
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226402238
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCF1NNP2

Total number of triples: 63.